A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/1997
11/04/1997	US5684204 Sulfur containing di-tert-butylphenol compounds useful as anti-inflammatory agents
11/04/1997	US5684160 3-aminopyrroles, methods for their synthesis and for their pharmaceutical use
11/04/1997	US5684046 Hydrogenated naphthalenes and related LTB4 antagonists
11/04/1997	US5684041 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
11/04/1997	US5684033 Antiarthritic agents, analgesics and migraine
11/04/1997	US5684031 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
11/04/1997	US5684017 Antiarthritic agents, rheumatic diseases, antidiabetic agents for inhibiting interloeukins
11/04/1997	US5684002 Dihydorbenzofuran and related compounds useful as anti-inflammatory agents
10/1997
10/30/1997	WO1997040158A1 Epimorphin antagonist and process for producing the same
10/30/1997	WO1997040073A2 BIOLOGICALLY ACTIVE PROTEIN (COLLAGEN FRAGMENT HF-COLL-18/514cf) FOR INHIBITING THE GROWTH OF TUMOURS AND CAPILLARY PROFILERATIONS
10/30/1997	WO1997040069A2 Secreted proteins and polynucleotides encoding them
10/30/1997	WO1997040032A1 Chiral phenyldihydrofuranones as pde-iv inhibitors
10/30/1997	WO1997040028A1 Urea derivatives as inhibitors of impdh enzyme
10/30/1997	WO1997040019A1 5-aminopyrazoles useful as selective inhibitors of the protein tyrosine kinase p56ick
10/30/1997	WO1997040012A1 Pyridinyl-2-cyclopenten-1-ones as selective cyclooxygenase-2 inhibitors
10/30/1997	WO1997035989A3 Cyclic nucleotide phosphodiesterase
10/30/1997	DE19617864A1 Neue chirale Phenyldihydrofuranone New chiral Phenyldihydrofuranone
10/30/1997	CA2252088A1 Secreted proteins and polynucleotides encoding them
10/29/1997	EP0803505A1 Inhibitors of metalloproteases, process for their preparation and pharmaceutical compositions containing them
10/29/1997	EP0802983A2 Expression of urokinase plasminogen activator inhibitors
10/29/1997	EP0802922A1 Novel amino acid derivatives, method of producing them and pharmaceutical compositions containing these compounds
10/29/1997	EP0802921A1 Human pak65
10/29/1997	EP0802917A1 Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents
10/29/1997	EP0802912A1 Piperidine derivatives having tachykinin antagonist activity
10/29/1997	EP0802908A1 Novel compounds
10/29/1997	EP0802897A1 Novel compounds
10/29/1997	EP0802791A1 3,3-(disubstituted)cyclohexan-1-ylidine acetate dimers and related compounds
10/29/1997	EP0471756B1 Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof
10/29/1997	CN1163656A Axial flow valve system for linear compressor
10/29/1997	CN1163613A 7-azabicyclo£2,2,1\|-heptane and heptene derivatives as cholinergic receptor ligands
10/29/1997	CN1163609A Modified polyunsatuated fatty acids
10/29/1997	CN1163104A Medicinal preparation containing shikimic acid and its derivatives, and its use in preparing anti-thrombosis and analgesic medicine
10/29/1997	CN1036263C Preparation of substituted azole
10/28/1997	US5681965 Alpha-phenyl tert-butyl nitrone and derivatives as free radical scavengers treating aging, oxidative tissue damage
10/28/1997	US5681940 Sugar modified nucleosides and oligonucleotides
10/28/1997	US5681858 Cycloalkyl hydroxyureas
10/28/1997	US5681747 Nucleic acid sequences encoding protein kinase C and antisense inhibition of expression thereof
10/28/1997	US5681577 Multiple action cold/sinus preparations
10/28/1997	CA2136825C Quaternary nitrogen-containing phosphonate compounds, for treating abnormal calcium and phosphate metabolism as well as dental calculus and plaque
10/23/1997	WO1997039126A1 Novel rantes homolog from prostate
10/23/1997	WO1997039123A2 Secreted proteins
10/23/1997	WO1997039018A1 New pregnane derivatives with no alpha-17 substitutent, their medicinal use, manufacturing method and its intermediaries and related compounds
10/23/1997	WO1997038992A1 Piperidinylpyramidine derivatives
10/23/1997	WO1997038986A1 Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors
10/23/1997	WO1997038977A1 Aminoisoquinolines and aminothienopyridine derivatives and their use as anti-inflammatory agents
10/23/1997	WO1997038966A2 Cytoprotective compounds
10/23/1997	WO1997038699A2 Use of alkylaryl polyether alcohol polymers for the treatment of chronic pulmonary inflammation
10/23/1997	WO1997038690A1 Agent for inhibiting leukocyte invasion of tissues
10/23/1997	WO1997038688A1 Methods of treating immunopathologies using polyunsaturated fattyacids
10/23/1997	WO1997038686A1 Use of an osmolyte for treating the effects of an infection, an inflammation or an immune dysfunction
10/23/1997	WO1997034565A3 Harpagoside-enriched extract from harpagophytum procumbens and processes for producing same
10/23/1997	WO1997034137A3 Methods of the identification of pharmaceutically active compounds
10/23/1997	WO1997026853A3 Dna encoding galanin galr2 receptors and uses thereof
10/23/1997	DE19615710A1 Verfahren zur Gewinnung und Anwendung eines biologisch aktiven Eiweisstoffes - Kollagenfragment HF-COLL-18/514cf - in partiell aufgereinigter und synthetischer Form aus Körperflüssigkeiten zur Beeinflussung des Zellwachstums und der Diagnose von Kollagenerkrankungen sowie der Osteoporose Methods for obtaining and application of a biologically active Eiweisstoffes - collagen fragment HF-COLL-18 / 514cf - in partially purified form from body fluids and synthetic for influencing the cell growth and the diagnosis of collagen diseases and osteoporosis
10/23/1997	CA2251780A1 Methods of treating immunopathologies using polyunsaturated fatty acids
10/23/1997	CA2251681A1 Aminoisoquinolines and aminothienopyridine derivatives and their use as anti-inflammatory agents
10/23/1997	CA2251642A1 New pregnane derivatives with no alpha-17 substitutent, their medicinal use, manufacturing method and its intermediaries and related compounds
10/23/1997	CA2251384A1 Use of alkylaryl polyether alcohol polymers for the inhibition of nuclear transcription factor nf-xb
10/23/1997	CA2251204A1 Use of an osmolyte for treating the effects of an infection, an inflammation or an immune dysfunction
10/23/1997	CA2251115A1 Novel rantes homolog from prostate
10/23/1997	CA2250943A1 Piperidinylpyrimidine derivatives
10/22/1997	EP0801951A2 Novel uses of Il-4 and/or Il-10, and antibodies against the same
10/22/1997	EP0801946A2 Use of salicin as agent against irritation in cosmetic and topical dermatological compositions
10/22/1997	EP0801945A2 Use of ferulic acid glucosides as agents against irritation in cosmetic or topical dermatological compositions
10/22/1997	EP0801676A2 New artificial tissue, method for the production and the use thereof
10/22/1997	EP0801574A1 Modulation of integrin-mediated signal transduction
10/22/1997	EP0801568A1 Compounds for inhibition of ceramide-mediated signal transduction
10/22/1997	EP0801567A1 1,3,3-(trisubstituted)cyclohex-1-ene monomers and related compounds
10/22/1997	EP0801563A1 The use of 2,3-alkylcarbonyloxybenzoic acid in treating adult respiratory distress syndrome
10/21/1997	US5679782 Inhibit receptor binding activity of urokinase-type plasminogen activator
10/21/1997	US5679684 Intiinflammatory agents, antiarthritis agents, nervous system disorders, aids
10/21/1997	US5679680 α-substituted hydrazides having calpain inhibitory activity
10/21/1997	US5679678 Analgesic and antiinflammatory agents
10/21/1997	US5679674 Analgesics
10/21/1997	US5679660 Pharmaceutical composition comprising diclofenac and cyclodextrin
10/21/1997	US5679644 Methods of treating diseases using triterpenoid acid derivatives
10/21/1997	US5679546 Chimeric proteins which block complement activation
10/21/1997	US5679374 Dispersion of lipid vesicles capable of penetrating into layers of skin and containing antimicrobial agents, n-(1-oxyl-2,2,6,6-tetramethyl-4-piperidyl)-n-dimethyl-n-hydro xyethylammonium iodide, antiinflammatory agents, retinol
10/21/1997	US5679339 Method of using IL-11 for treating spondyloarthropies
10/16/1997	WO1997038095A1 Complex superoxide dismutase product
10/16/1997	WO1997038084A2 Polynucleotides derived from a pbmc cdna library encoding secreted proteins
10/16/1997	WO1997038007A1 Peptidyl compounds having mmp and tnf- liberation inhibitory activity
10/16/1997	WO1997037988A1 Acylated n-hydroxy methyl thalidomide prodrugs with immunomodulator action
10/16/1997	WO1997037974A1 Peptidyl compounds having mmp and tnf inhibitory activity
10/16/1997	WO1997037973A1 Peptidyl compounds having mmp and tnf inhibitory activity
10/16/1997	WO1997037972A1 Novel vitamin d analogues
10/16/1997	WO1997037676A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins
10/16/1997	WO1997037655A1 αvβ3 ANTAGONISTS
10/16/1997	WO1997022619A3 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
10/16/1997	CA2251017A1 .alpha.v.beta.3 antagonists
10/16/1997	CA2250860A1 Polynucleotides encoding secreted proteins
10/16/1997	CA2250835A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins
10/16/1997	CA2248949A1 Novel furan diarylmethylidene derivatives, method for their preparation and therapeutical uses thereof
10/16/1997	CA2248082A1 Peptidyl compounds having mmp and tnf- liberation inhibitory activity
10/16/1997	CA2248070A1 Peptidyl compounds having mmp and tnf inhibitory activity
10/16/1997	CA2247964A1 Peptidyl compounds having mmp and tnf inhibitory activity
10/15/1997	EP0801067A1 Novel quinuclidine derivatives and medicinal composition thereof
10/15/1997	EP0800535A1 Fibronectin adhesion inhibitors
10/15/1997	EP0800534A2 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases
10/15/1997	EP0800533A1 Anti-inflammatory cd14 peptides

1 ... 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 ... 1272